MHRA Appoints New Chief Executive

News Jul 05, 2013

He will take up the post in September when current Chief Executive Sir Kent Woods steps down, after ten years with the agency.

Dr Hudson is currently the MHRA’s Licensing Director, responsible for the majority of medicines licensing activities. He is the UK delegate to the Committee on Human Medicinal Products (CHMP) at the European Medicines Agency and has been its vice-chairman since October 2012.

In line with Government protocol, the Department of Health officially announced the appointment and their press release is available through the link below.

Scientists Develop Platform to Kill Cancer Cells

News

For the first time ever, scientists have shown that a hybrid nanomaterial based on magnetite-gold particles can serve as a universal platform to both detect cancer cells anywhere in the body and to complete targeted deliveries of drugs to these cells.

Molecular Switch May Serve as New Target for Cancer and Diabetes Therapies

News

If certain signaling cascades are misregulated, diseases like cancer, obesity and diabetes may occur. A recently discovered mechanism has a crucial influence on such signaling cascades and may be an important key for the future development of therapies against these diseases.